Suchergebnisse - "Malone, Daniel"

PubPharm (568)

61

Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management

enthalten in: Drug safety | 2022

von Hansten, P. | Tan, M. | Horn, J. | +7

62

Colchicine and macrolides : a cohort study of the risk of adverse outcomes associated with concomitant exposure

enthalten in: Rheumatology international | 2022

von Tan, M. | Gomez-Lumbreras, A. | Villa-Zapata, L. | +1

63

Authors' Response to Yoshihiro Noguchi's Comment on : "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"

enthalten in: Drug safety | 2022

von Malone, D. | Villa-Zapata, L. | Gómez-Lumbreras, A. | +3

CommentOn: Drug Saf. 2022 Aug;45(8):863-871. - PMID 35834155

64

Risk of Bleeding Among Individuals on Direct-Acting Oral Anticoagulants : An Academic Medical Center Cohort Study

enthalten in: Journal of cardiovascular pharmacology | 2022

von Gomez Lumbreras, A. | Tan, M. | Moorman-Bishir, K. | +2

65

Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation : Electronic Health Record Analysis

enthalten in: Journal of medical Internet research | 2022

von Simon, S. | Trinkley, K. | Malone, D. | +1

66

Shared Decision-Making for Drug-Drug Interactions : Formative Evaluation of an Anticoagulant Drug Interaction

enthalten in: JMIR formative research | 2022

von Gomez Lumbreras, A. | Reese, T. | Del Fiol, G. | +8

67

Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”

enthalten in: Drug safety | 2022

von Malone, D. | Villa-Zapata, L. | Gómez-Lumbreras, A. | +3

68

Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”

enthalten in: Drug safety | 2022

von Malone, D. | Villa-Zapata, L. | Gómez-Lumbreras, A. | +3

69

Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”

enthalten in: Drug safety | 2022

von Malone, D. | Villa-Zapata, L. | Gómez-Lumbreras, A. | +3

70

Exploring cognitive apprenticeship and teaching practices in pharmacy education

enthalten in: Advances in health sciences education : theory and practice | 2022

von Minshew, L. | Malone, D. | Cain, J. | +1